Schedule 13G ownership disclosure
ONCOMED PHARMACEUTICALS INC
Security class unavailable · CUSIP: 68234X102
Event date: 2017-05-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,503,600
- Percent of class
- 14.6300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-037641
- Form type
- SC 13G
- Filer
- OncoMed Pharmaceuticals Inc
- CIK
- CIK 1302573
- Filed
- Jun 06, 2017
- Reporting period
- May 31, 2017
- Description
- Schedule 13G beneficial ownership